BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $4,613 (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 41.5%

Value ($000) $1,912 Shares 60,632,356 Est. Cost $16.58 Unrealized —

SGRY SURGERY PARTNERS INC 35.2%

Value ($000) $1,623 Shares 58,248,249 Est. Cost $31.75 Unrealized -16.6%

— DIVERSEY HLDGS LTD 21.8%

Value ($000) $1,008 Shares 236,561,159 Est. Cost $14.71 Unrealized —

AVAH AVEANNA HEALTHCARE HLDGS INC 1.4%

Value ($000) $64 Shares 81,600,880 Est. Cost $11.86 Unrealized -91.2%

ADV ADVANTAGE SOLUTIONS INC 0.1%

Value ($000) $6 Shares 2,890,000 Est. Cost $10.52 Unrealized -76.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1,912	41.5%	$16.58	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	58,248,249	$1,623	35.2%	$31.75	-16.6%	COM	86881A100
—	DIVERSEY HLDGS LTD	236,561,159	$1,008	21.8%	$14.71	—	ORD SHS	G28923103
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$64	1.4%	$11.86	-91.2%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$6	0.1%	$10.52	-76.1%	COM CL A	00791N102